Irinotecan (CPT-11)-induced elevation of bile acids potentiates suppression of IL-10 expression
- 1 January 2016
- journal article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 291, 21-27
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81202586)
- Tianjin Project of Thousand Youth Talents (BS2013YY054, ZR2010HL023)
- Natural Science Foundation of Shandong Province
This publication has 24 references indexed in Scilit:
- Implication of intestinal VDR deficiency in inflammatory bowel diseaseBiochimica et Biophysica Acta (BBA) - General Subjects, 2013
- Dysfunction of Organic Anion Transporting Polypeptide 1a1 Alters Intestinal Bacteria and Bile Acid Metabolism in MicePLOS ONE, 2012
- Balancing acts: the role of TGF-β in the mucosal immune systemTrends in Molecular Medicine, 2011
- Colitis and Intestinal Inflammation in IL10 Mice Results From IL-13Rα2–Mediated Attenuation of IL-13 ActivityGastroenterology, 2011
- Intestinal T cells: Facing the mucosal immune dilemma with synergy and diversitySeminars in Immunology, 2009
- Commensal DNA Limits Regulatory T Cell Conversion and Is a Natural Adjuvant of Intestinal Immune ResponsesImmunity, 2008
- Nutritional Modulation of Antitumor Efficacy and Diarrhea Toxicity Related to Irinotecan Chemotherapy in Rats Bearing the Ward Colon TumorClinical Cancer Research, 2007
- A Unique Subset of Self-specific Intraintestinal T Cells Maintains Gut IntegrityJournal of Experimental Medicine, 2002
- Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes.Journal of Clinical Investigation, 1998
- Interleukin-10 gene knock-out mice: a model of chronic inflammationClinical Immunology and Immunopathology, 1995